Black checkmark with a sparkle and a curved line underneath on a white background.
Company

GBT Technologies Inc.

Ticker
GTCH
Sector
Industry
Report date
August 20, 2026
Valye AI Score

67

High visibility
Recent developments
Recent developments summary

Recent developments highlight GBT Technologies' strategic initiatives including the formation of subsidiaries focused on AI-powered wellness and digital media, expansion of AI wellness machines, and key personnel appointments.

Recent developments:
  • GBT Technologies announced the formation of Cube X Media to launch a national digital media and content platform [N4].
  • The company’s Cube Wellness subsidiary expanded its rollout to 36 AI-powered digital wellness machines, advancing a scalable campus health platform [N4].
  • GBT Technologies appointed filmmaker Minh Collins as President of Cube X Media subsidiary [N4].
  • The company formed Cube Wellness Technologies to deploy AI-enabled wellness infrastructure through strategic institutional partnerships and appointed a new interim CEO, Patrick Bertagna [N4].
  • GBT Technologies announced a non-binding offer to acquire Two Hands Corporation as part of its merchant banking strategy [N4].
  • The company intends to rebrand as Wertheim & Company and appointed Craig Marshak as CEO, with Emil Assentato joining as a strategic investor [N4].
Overview

GBT Technologies Inc. is a company operating in a rapidly evolving technology industry with a focus on AI-driven solutions and integrated circuit technologies. The company has a limited operating history and has not yet achieved profitability. It has developed a portfolio of intellectual property including patents for integrated circuits, AI-driven electronic design automation tools, and human vitals monitoring devices. GBT has formed subsidiaries such as Cube Wellness Technologies, which deploys AI-powered digital wellness machines, and Cube X Media, a digital media and content platform. The company is pursuing growth through strategic acquisitions and rebranding efforts. Financially, GBT Technologies has a significant accumulated deficit and stockholders' deficit, with liquidity ratios indicating limited current assets relative to liabilities. The company funds operations through equity and debt financing and plans to raise additional capital to support its business plan. GBT Technologies' common stock trades on the OTC marketplace under the ticker GTCH, characterized by limited liquidity and high volatility.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. GBT Technologies Inc. operates in an evolving industry with a limited operating history and has not achieved profitability. The company reported a net loss of $573,651 for the six months ended June 30, 2026, and has a significant stockholders' deficit and accumulated deficit. Liquidity ratios as of June 30, 2026, indicate very limited liquidity. The company funds operations primarily through equity and debt issuances and plans to raise additional capital to support growth. GBT Technologies trades on the OTC marketplace with a limited public market and experiences high stock price volatility. The company has formed subsidiaries to expand into AI-powered wellness and digital media sectors and holds a portfolio of patents related to integrated circuits and AI technologies. Risks include limited operating history, capital requirements, market volatility, and execution challenges [S1][S2].

Scenarios for GTCH

Bull case model:

GBT Technologies has developed a diverse portfolio of patents in integrated circuits and AI technologies, which could provide a foundation for innovative product offerings. The formation of subsidiaries focused on AI-powered wellness machines and digital media platforms indicates strategic diversification and potential for scalable growth. The company's merchant banking strategy and planned acquisitions may enhance its market position and operational capabilities. If the company successfully executes its business plan and capitalizes on its intellectual property, it could strengthen its presence in emerging technology sectors.

Bear case model:

GBT Technologies faces significant challenges including a limited operating history, ongoing net losses, and very limited liquidity as indicated by low current and cash ratios. The company depends heavily on raising additional capital, which may not be available on favorable terms and could dilute existing shareholders. Trading on the OTC marketplace exposes the stock to high volatility and limited liquidity, complicating investor exit options. Execution risks include the ability to expand the business, integrate acquisitions, adapt to rapidly evolving technology trends, and manage growth effectively. Failure to address these risks could adversely affect the company's financial condition and business prospects.

Moat:

GBT Technologies' moat is primarily based on its intellectual property portfolio, which includes patents related to integrated circuit design, AI-driven electronic design automation tools, and human vitals monitoring devices. These patents provide technological differentiation in specialized areas of semiconductor and AI applications. The company's efforts to expand into AI-powered wellness infrastructure and digital media platforms through subsidiaries may create additional competitive advantages if successfully executed. However, the company's limited operating history and evolving industry context present challenges to establishing a durable competitive moat.

Risks overview
Risks summary
The most significant risks for GBT Technologies stem from its limited operating history, ongoing losses, liquidity constraints, and dependence on raising additional capital, combined with execution challenges in a rapidly evolving industry and a volatile, illiquid stock market environment.
Risks details:

• Limited Operating History and Evolving Industry: GBT Technologies has a limited operating history in a rapidly evolving industry, making it difficult to evaluate future prospects and increasing the risk of unsuccessful business outcomes.
• Lack of Profitability and Negative Cash Flow: The company has not achieved profitability and has not generated positive cash flow from operations since inception, relying on equity and debt financing to fund operations.
• Liquidity Constraints: Liquidity ratios as of June 30, 2026, show a current ratio and cash ratio of 0.01, indicating very limited liquidity and potential challenges in meeting short-term obligations.
• Capital Requirements and Dilution Risk: GBT Technologies requires substantial capital to support growth and operations, with plans to raise approximately $10 million. Future equity or debt financing could dilute existing shareholders and impose restrictive covenants.
• Market and Stock Volatility: The company's common stock trades on the OTC marketplace with a limited public market, leading to high volatility, low trading volume, and potential difficulties in buying or selling shares.
• Execution and Growth Risks: Risks include the ability to accurately forecast revenues, expand the business, assimilate acquisitions, adapt to technology trends, develop scalable infrastructure, and retain key personnel.
• Internal Controls and Reporting Risks: Past disclosures indicate weaknesses in internal controls and disclosure procedures, which could affect financial reporting reliability and investor confidence.

FINAL FORECAST FOR GTCH

Final take one line
GBT Technologies Inc. operates in a challenging evolving industry with limited operating history, ongoing losses, and liquidity constraints, while pursuing growth through AI-driven technologies and strategic subsidiaries.
Final take 12 to 24 month view

Business trends: The company is expanding into AI-powered wellness and digital media sectors, leveraging its intellectual property portfolio and pursuing strategic acquisitions.
Execution milestones: Formation and expansion of subsidiaries Cube Wellness Technologies and Cube X Media, appointment of key personnel, and capital raising efforts.
Key risks: Limited operating history, ongoing net losses, liquidity challenges, dependence on capital markets, execution risks, and stock market volatility.

Valye AI Visibility Research Score

High visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

67
LLM visibility overview
LLM Visibility known facts
Sources
Sources - Context summary

Generated 2026-08-20

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-04-15 | 10-K
  • S2 | 2026-08-19 | 10-Q
Sources - News headlines
  • N1 | 2026-08-20 | www.nasdaq.com | Mark Zuckerberg's Meta Saw Free Cash Flow Plunge 91% to Just $784 Million as AI Spending Ballooned. Here's Why That Should Worry Investors. | https://www.nasdaq.com/articles/mark-zuckerbergs-meta-saw-free-cash-flow-plunge-91-just-784-million-ai-spending-ballooned
  • N2 | 2026-08-20 | www.nasdaq.com | Ross Stores Q2 26 Earnings Conference Call At 4:15 PM ET | https://www.nasdaq.com/articles/ross-stores-q2-26-earnings-conference-call-4-15-pm-et
  • N3 | 2026-08-20 | www.nasdaq.com | Deere And Co Q3 26 Earnings Conference Call At 10:00 AM ET | https://www.nasdaq.com/articles/deere-and-co-q3-26-earnings-conference-call-10-00-am-et
  • N4 | 2026-08-20 | www.nasdaq.com | Walmart Q2 27 Earnings Conference Call At 8:00 AM ET | https://www.nasdaq.com/articles/walmart-q2-27-earnings-conference-call-8-00-am-et
  • N5 | 2026-08-20 | www.nasdaq.com | BOC Aviation H1 Profit Rises, Passenger Traffic Growth Slows; Sees Demand Growth Ahead | https://www.nasdaq.com/articles/boc-aviation-h1-profit-rises-passenger-traffic-growth-slows-sees-demand-growth-ahead
  • N6 | 2026-08-20 | www.nasdaq.com | AI Stocks Have Soared. Is It Too Late to Buy This Vanguard ETF? | https://www.nasdaq.com/articles/ai-stocks-have-soared-it-too-late-buy-vanguard-etf
  • N7 | 2026-08-20 | www.nasdaq.com | Alvotech Q2 Revenue Falls 38.9%; FDA Decisions Ahead For AVT05 And AVT06 Biosimilars In Q4 | https://www.nasdaq.com/articles/alvotech-q2-revenue-falls-389-fda-decisions-ahead-avt05-and-avt06-biosimilars-q4
  • N8 | 2026-08-20 | www.nasdaq.com | DNA X Posts Q2 Results, Balance Sheet Restructuring Supports AI Platform Transition | https://www.nasdaq.com/articles/dna-x-posts-q2-results-balance-sheet-restructuring-supports-ai-platform-transition
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine